vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Karyopharm Therapeutics Inc. is the larger business by last-quarter revenue ($34.1M vs $27.6M, roughly 1.2× Maison Solutions Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -299.9%, a 281.9% gap on every dollar of revenue. On growth, Karyopharm Therapeutics Inc. posted the faster year-over-year revenue change (11.6% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 1.4%).
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
KPTI vs MSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $27.6M |
| Net Profit | $-102.2M | $-5.0M |
| Gross Margin | — | 23.4% |
| Operating Margin | -52.4% | -4.9% |
| Net Margin | -299.9% | -18.0% |
| Revenue YoY | 11.6% | -10.9% |
| Net Profit YoY | -232.0% | -1840.5% |
| EPS (diluted) | $-7.02 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $27.6M | ||
| Q3 25 | $44.0M | $27.2M | ||
| Q2 25 | $37.9M | $34.4M | ||
| Q1 25 | $30.0M | $32.3M | ||
| Q4 24 | $30.5M | $29.4M | ||
| Q3 24 | $38.8M | $28.2M | ||
| Q2 24 | $42.8M | $16.9M | ||
| Q1 24 | $33.1M | $13.6M |
| Q4 25 | $-102.2M | $-5.0M | ||
| Q3 25 | $-33.1M | $-1.5M | ||
| Q2 25 | $-37.3M | $-287.4K | ||
| Q1 25 | $-23.5M | $1.0M | ||
| Q4 24 | $-30.8M | $-256.0K | ||
| Q3 24 | $-32.1M | $700.9K | ||
| Q2 24 | $23.8M | $-2.8M | ||
| Q1 24 | $-37.4M | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 23.4% |
| Q4 25 | -52.4% | -4.9% | ||
| Q3 25 | -34.6% | 0.7% | ||
| Q2 25 | -64.3% | -15.9% | ||
| Q1 25 | -110.8% | 3.7% | ||
| Q4 24 | -102.4% | 3.2% | ||
| Q3 24 | -67.8% | 7.3% | ||
| Q2 24 | -65.7% | -14.4% | ||
| Q1 24 | -101.9% | -2.3% |
| Q4 25 | -299.9% | -18.0% | ||
| Q3 25 | -75.2% | -5.7% | ||
| Q2 25 | -98.2% | -0.8% | ||
| Q1 25 | -78.2% | 3.1% | ||
| Q4 24 | -100.8% | -0.9% | ||
| Q3 24 | -82.7% | 2.5% | ||
| Q2 24 | 55.6% | -16.4% | ||
| Q1 24 | -112.8% | -4.0% |
| Q4 25 | $-7.02 | $-0.23 | ||
| Q3 25 | $-3.82 | $-0.08 | ||
| Q2 25 | $-4.32 | $-0.02 | ||
| Q1 25 | $-2.77 | $0.06 | ||
| Q4 24 | $-2.33 | $-0.01 | ||
| Q3 24 | $-3.85 | $0.04 | ||
| Q2 24 | $-2.97 | $-0.16 | ||
| Q1 24 | $-4.85 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $-292.9M | $11.6M |
| Total Assets | $108.4M | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | — | ||
| Q3 25 | $37.7M | $1.1M | ||
| Q2 25 | $38.7M | $775.4K | ||
| Q1 25 | $38.8M | $445.4K | ||
| Q4 24 | $62.5M | $355.7K | ||
| Q3 24 | $72.8M | $588.9K | ||
| Q2 24 | $84.8M | $2.1M | ||
| Q1 24 | $30.6M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $-292.9M | $11.6M | ||
| Q3 25 | $-269.3M | $10.1M | ||
| Q2 25 | $-238.9M | $11.7M | ||
| Q1 25 | $-205.9M | $12.0M | ||
| Q4 24 | $-186.0M | $10.9M | ||
| Q3 24 | $-159.6M | $11.2M | ||
| Q2 24 | $-132.1M | $10.5M | ||
| Q1 24 | $-169.0M | $13.3M |
| Q4 25 | $108.4M | $75.4M | ||
| Q3 25 | $96.2M | $73.3M | ||
| Q2 25 | $104.9M | $77.4M | ||
| Q1 25 | $127.7M | $82.7M | ||
| Q4 24 | $164.4M | $82.7M | ||
| Q3 24 | $189.5M | $82.1M | ||
| Q2 24 | $214.0M | $82.4M | ||
| Q1 24 | $204.5M | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $-1.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $-1.7M | ||
| Q3 25 | $-5.9M | $1.1M | ||
| Q2 25 | $-18.7M | $-1.6M | ||
| Q1 25 | $-39.0M | $1.7M | ||
| Q4 24 | $-25.8M | $1.1M | ||
| Q3 24 | $-19.5M | $3.6M | ||
| Q2 24 | $-38.5M | $-2.6M | ||
| Q1 24 | $-43.7M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-43.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -84.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -132.6% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | -1.62× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
